К содержанию
РецензированоUZ2022

Surgical treatment of a patient with erythromelalgia (Mitchell’s syndrome) using invasive spinal cord stimulation: A Clinical case

Vachtang G. Toriya · Sergei V. Vissarionov · Margarita V. Savina · Alexey G. Baindurashvili

Научные статьи · 2022

Аннотация

Erythromelalgia is a rare hereditary disorder manifesting the basic triad of symptoms: erythro – redness, melos – limb, and algos – pain. It was first described by the American neurologist, S. Weir Mitchell in 1878. Clinical manifestations of the disease worsen the physical and psychological condition of the patient leading to reduced quality of life, increased morbidity and mortality. Currently, etiotropic therapy for erythromelalgia that demonstrates high efficacy in individuals with this pathology, has not been developed. Moreover, there is no consensus on treatment strategies for this category of patients, emphasized by the absence of clinical guidelines for the treatment of erythromelalgia. Treatment of patients with erythromelalgia is currently based on sequential pharmacotherapy in order to select the most effective therapy

Доказательный фрагмент

«Erythromelalgia is a rare hereditary disorder manifesting the basic triad of symptoms: erythro – redness, melos – limb, and algos – pain.»

Образец извлечения

Демо-превью

Erythromelalgia is a rare hereditary disorder manifesting the basic triad of symptoms: erythro – redness, melos – limb, and algos – pain. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники